DelveInsight’s Degenerative Disc Disease Market Insights Report offers a detailed analysis of disease, its causes, symptoms, diagnostics modalities, and treatment options. The report also offers comprehensive insights into Degenerative Disc Disease market size, epidemiology, emerging therapies, market drivers, market barriers, ongoing clinical trials, key collaboration in the space, and major pharmaceutical companies actively involved in the therapeutics market.
Some of the key highlights from the Degenerative Disc Disease Market Insights:
- As per the study conducted by Senglaub et al. 2018, 266 million individuals (3.63%) worldwide are diagnosed with lumbar degenerative spine disease (DSD) yearly and the highest estimated incidence was observed to be in Europe (5.7%; 5668 per 100 000).
- In the United States, nearly 80% of adults experience at least one episode of low back pain during their lifetime, and 5% experience chronic problems. An understanding of degenerative disk disease is important for managing these patients. [Stephen Kishner et al. 2019].
- As per the study of Loyola University Medical Center, females present more chronic pain conditions as compared to males (3:2) but the Degenerative Disc Disease prevalence is almost similar and Females are 1.38 times more likely to have cervical DDD.
- Globally, some of the key companies in the Degenerative Disc Disease Market such as Benvenue Medical, Spinal Simplicity, DiscGenics, Mesoblast, SpinalCyte, BioRestorative Therapies, and Tetec are involved in developing therapies.
- The expected launch of emerging Degenerative Disc Disease therapies such as IDCT, ALLOB, Minuteman Fusion Implant, and others would lead to a significant increase in the market size during the forecast period.
- As per DelveInsight, the Degenerative disk Disease Market is expected to observe significant growth in upcoming years due to the factors such as raising awareness of the disease, surge in funds for DDD clinical trials, and incremental healthcare spending across the world.
Learn more by requesting for sample @ Degenerative Disc Disease Market Landscape
Degenerative Disc Disease: Overview
Degenerative Disk Disease (DDD- osteochondrosis intervertebralis) is an age-related chronic condition that is characterized by progressive degeneration of the intervertebral discs. As per the WHO (2018), low back pain is one of the most prevalent problems in industrialized countries with the prevalence ranging from 60% to 90% and the top global cause of years lived with disability. There are a number of contributors to low back pain, one of which is DDD of the spine. Similarly, according to the study conducted by Dariusz Mydlarz et al. (2012), the estimated Degenerative Disc Disease prevalence in the general population range from 3 to 56 percent.
For more insights into Disease, causes, and treatment, reach out @ Degenerative Disc Disease Treatment Landscape
Degenerative Disc Disease Epidemiology Segmentation
The Degenerative Disc Disease Market report proffers epidemiological analysis for the study period 2017-30 in the 7MM segmented into:
- Diagnosed and Treatable Population of Degenerative Disk Disease
- Total Prevalent Cases of Degenerative Disk Disease
- Gender-specific Prevalent Pool of Degenerative Disk Disease
- Disk Degeneration prevalence by spinal regions
- Age-specific Prevalent Pool of Degenerative Disk Disease
Visit for more @ Degenerative Disc Disease Epidemiological Insights
Degenerative Disc Disease Market
Currently, the Degenerative Disc Disease therapeutics approaches include physical therapy, chiropractic manipulative therapy, osteopathic manipulation, anti-inflammatory medications (such as non-steroidal anti-inflammatory drugs (NSAIDs)), and/or spinal injections, epidural steroid injections that can provide pain relief. If these more moderate approaches fail to alleviate symptoms, in some cases surgery is also conducted.
Several companies are focusing on modalities that aim to reverse the degenerative cascade through the use of biologics and gene modification. The ongoing research and development (R&D) activities and the emerging therapies for the Degenerative Disc Disease pipeline bring a positive ray of hope for potential treatment options in the market in the upcoming years. With the launch of the emerging therapies, the current treatment scenario is expected to observe a positive shift in the market for a study period.
Degenerative Disc Disease Pipeline Therapies and Key Companies
- IDCT – DiscGenics
- Minuteman Fusion Implant – Spinal Simplicity
- ALLOB – Bone Therapeutics
For more information, visit Degenerative Disc Disease Market Analysis, Patient Pool, and Emerging Therapies
Degenerative Disc Disease Market Drivers
- Improvement in diagnosis methodologies
- Increasing advances in regenerative medicine
- Incremental healthcare spending across the world
Scope of the Report
- 11 Years Forecast
- 7MM Coverage
- Descriptive overview of Degenerative Disc Disease, covering causes, signs and symptoms, pathophysiology, diagnosis, and currently available therapies
- Comprehensive insight into Degenerative Disc Disease epidemiology and treatment in the 7MM
- Current and emerging therapies for Degenerative Disc Disease
- Degenerative Disc Disease market drivers and barriers
Key Questions Answered in the Report
- What was the Degenerative Disc Disease market share (%) distribution in 2017 and how it would look like in 2030?
- What would be the Degenerative Disc Disease total market size as well as market size by therapies across the 7MM during the forecast period (2017-2030)?
- What are the key findings pertaining to the market across 7MM and which country will have the largest Degenerative Disc Disease market size during the forecast period (2017-2030)?
- At what CAGR, the Degenerative Disc Disease market is expected to grow in 7MM during the forecast period (2017-2030)?
Get in touch with our Business executive @ Degenerative Disc Disease Market Landscape Analysis
Table of Contents
|
1 |
Key Insights |
|
2 |
Report Introduction |
|
3 |
Competitive Intelligence Analysis for Degenerative Disc Disease |
|
4 |
Degenerative Disc Disease Market Overview at a Glance |
|
5 |
Executive Summary of Degenerative Disc Disease |
|
6 |
Degenerative Disc Disease Epidemiology and Market Methodology |
|
7 |
Degenerative Disc Disease Epidemiology and Patient Population |
|
8 |
Degenerative Disc Disease Patient Journey |
|
9 |
Treatment Algorithm, Current Treatment, and Medical Practices |
|
10 |
Key Endpoints in Degenerative Disc Disease Clinical Trials |
|
11 |
Degenerative Disc Disease Marketed Therapies |
|
12 |
Degenerative Disc Disease Emerging Therapies |
|
13 |
Degenerative Disc Disease: 7 Major Market Analysis |
|
14 |
Attribute analysis |
|
15 |
Access and Reimbursement Overview of Degenerative Disc Disease |
|
16 |
KOL Reviews |
|
17 |
Case Reports |
|
18 |
Degenerative Disc Disease Market Drivers |
|
19 |
Degenerative Disc Disease Market Barriers |
|
20 |
SWOT Analysis |
|
21 |
Disclaimer |
|
22 |
DelveInsight Capabilities |
|
23 |
About DelveInsight |
Learn more about the report offerings @ Degenerative Disc Disease Market Outlook
Related Reports –
Degenerative Disc Disease (DDD) Epidemiology Forecast
DelveInsight’s Degenerative Disc Disease (DDD) Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Degenerative Disc Disease (DDD) in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan
Degenerative Disc Disease Pipeline Insights
Degenerative Disc Disease Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Degenerative Disc Disease market.
Global Kinase Inhibitor in Autoimmune Diseases Market
DelveInsight’s “Global Kinase Inhibitor in Autoimmune Diseases Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Global Kinase Inhibitor in Autoimmune Diseases market size, shares and trends analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
Muscle Atrophy/ Wasting Syndrome Market
DelveInsight’s “Muscle Atrophy/ Wasting Syndrome Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Muscle Atrophy/ Wasting Syndrome market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
Corneal Endothelial Dystrophy Market
DelveInsight’s “Corneal Endothelial Dystrophy Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Corneal Endothelial Dystrophy market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
Metrorrhagia Market Insight
DelveInsight’s “Metrorrhagia Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Metrorrhagia market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
Dysfunctional Uterine Bleeding Market
DelveInsight’s “Dysfunctional Uterine Bleeding Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Dysfunctional Uterine Bleeding market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
mRNA Vaccines and Therapeutics Market
DelveInsight’s ‘Global Messenger RNA (mRNA) based Vaccines and Therapeutics Market Insights, Epidemiology, and Market Forecast 2030’ report deliver an in-depth understanding of the mRNA-based Vaccines and Therapeutics, along with its historical and forecasted epidemiology and market trends in North America, Europe, Asia, and ROW (rest of the world).
Guillain-Barre Syndrome (GBS) Market
DelveInsight’s “Guillain-Barre Syndrome (GBS) Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Guillain-Barre Syndrome (GBS) market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
- Neurological Disease Therapy Market
- Non-small Cell Lung Cancer Therapy Market
- Primary Hyperoxaluria Market Clinical Trials
- Crohn’s Disease Treatment Market
- Leading Musculoskeletal Disorders and Key Companies
- Peanut Allergy Therapy Market
- Key Companies in the Transcranial Stimulation Devices Market
- Uncomplicated Urinary Tract Infections Market Size
- Autoimmune Diseases Treatment Landscape
- Insulin Delivery Devices Market Size
- Companies in FemTech Market
- Common Types of Skin Cancers
- Key Companies in Cardiac Monitoring Devices Market
- Janus Kinase Inhibitors Market
- Technological Innovation in Healthcare
- Von Hippel-Lindau Market
- Fecal Incontinence Therapy Market
- Advances in the Management of Diabetes
- Major Depressive Disorder Treatment Market
- Virtual Clinical Trials Future outlook
Get in touch with our Business executive for Competitive Intelligence Services
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Connect With Us at LinkedIn | Facebook | Twitter
Contact Information:
Shruti Thakur info@delveinsight.com +91-9650213330
Tags:
Menafn, IPS, Reportedtimes, PR-Wirein, Extended Distribution, iCN Internal Distribution, Research Newswire, English
Contact Information:
Shruti Thakur info@delveinsight.com +91-9650213330
